Cantado para nadie /

le Cervantes, Francisco.
Foilsithe 1982.

Heridas que se alternan /

le Cervantes, Francisco.
Foilsithe 1985.

A Problem-Oriented Approach for Dynamic Verification of Heterogeneous Embedded Systems

le Mendoza Cervantes, Francisco
Foilsithe 2013

Vida y obra de Fernando Pessoa : história de una generación /

le Simões, João Gaspar, Cervantes, Francisco.
Foilsithe 1987.

JAK inhibitors: beyond spleen and symptoms?

le Cervantes, Francisco, Mesa, Ruben, Harrison, Claire
Foilsithe 2013

Blood cell activation in myeloproliferative neoplasms

le Cervantes, Francisco, Arellano-Rodrigo, Eduardo, Alvarez-Larrán, Alberto
Foilsithe 2009

Novel Therapies for Myelofibrosis

le Stein, Brady L., Cervantes, Francisco, Giles, Francis, Harrison, Claire N., Verstovsek, Srdan
Foilsithe in Leuk Lymphoma (2015)

Anaerobic Mineralization of Toluene by Enriched Sediments with Quinones and Humus as Terminal Electron Acceptors

le Cervantes, Francisco J., Dijksma, Wouter, Duong-Dac, Tuan, Ivanova, Anna, Lettinga, Gatze, Field, Jim A.
Foilsithe 2001

Conventional and molecular cytogenetic studies to characterize 32 complex variant Philadelphia translocations in patients with chronic myeloid leukemia

le Costa, Dolors, Grau, Javier, Espinet, Blanca, Arias, Amparo, Gómez, Cándida, López-Guerra, Mónica, Nomdedeu, Meritxell, Cervantes, Francisco
Foilsithe in Oncol Lett (2019)

Humic Substances Mediate Anaerobic Methane Oxidation Linked to Nitrous Oxide Reduction in Wetland Sediments

le Valenzuela, Edgardo I., Padilla-Loma, Claudia, Gómez-Hernández, Nicolás, López-Lozano, Nguyen E., Casas-Flores, Sergio, Cervantes, Francisco J.
Foilsithe in Front Microbiol (2020)

Safety and efficacy of the combination of sonidegib and ruxolitinib in myelofibrosis: a phase 1b/2 dose-finding study

le Gupta, Vikas, Wolleschak, Denise, Hasselbalch, Hans, Vannucchi, Alessandro Maria, Koschmieder, Steffen, Cervantes, Francisco, Li, Yang, Dong, Tuochuan, Wroclawska, Monika, Bharathy, Savita, Harrison, Claire
Foilsithe in Blood Adv (2020)

Anaerobic Methane Oxidation Driven by Microbial Reduction of Natural Organic Matter in a Tropical Wetland

le Valenzuela, Edgardo I., Prieto-Davó, Alejandra, López-Lozano, Nguyen E., Hernández-Eligio, Alberto, Vega-Alvarado, Leticia, Juárez, Katy, García-González, Ana Sarahí, López, Mercedes G., Cervantes, Francisco J.
Foilsithe in Appl Environ Microbiol (2017)

Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis

le Kröger, Nicolaus, Giorgino, Toni, Scott, Bart L., Ditschkowski, Markus, Alchalby, Haefaa, Cervantes, Francisco, Vannucchi, Alessandro, Cazzola, Mario, Morra, Enrica, Zabelina, Tatjana, Maffioli, Margherita, Pereira, Arturo, Beelen, Dietrich, Deeg, H. Joachim, Passamonti, Francesco
Foilsithe in Blood (2015)

Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses

le Verstovsek, Srdan, Gotlib, Jason, Mesa, Ruben A., Vannucchi, Alessandro M., Kiladjian, Jean-Jacques, Cervantes, Francisco, Harrison, Claire N., Paquette, Ronald, Sun, William, Naim, Ahmad, Langmuir, Peter, Dong, Tuochuan, Gopalakrishna, Prashanth, Gupta, Vikas
Foilsithe in J Hematol Oncol (2017)

Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus repo...

le Tefferi, Ayalew, Cervantes, Francisco, Mesa, Ruben, Passamonti, Francesco, Verstovsek, Srdan, Vannucchi, Alessandro M., Gotlib, Jason, Dupriez, Brigitte, Pardanani, Animesh, Harrison, Claire, Hoffman, Ronald, Gisslinger, Heinz, Kröger, Nicolaus, Thiele, Juergen, Barbui, Tiziano, Barosi, Giovanni
Foilsithe in Blood (2013)

A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis

le Vannucchi, Alessandro M., Kantarjian, Hagop M., Kiladjian, Jean-Jacques, Gotlib, Jason, Cervantes, Francisco, Mesa, Ruben A., Sarlis, Nicholas J., Peng, Wei, Sandor, Victor, Gopalakrishna, Prashanth, Hmissi, Abdel, Stalbovskaya, Viktoriya, Gupta, Vikas, Harrison, Claire, Verstovsek, Srdan
Foilsithe in Haematologica (2015)

SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor–Naïve Patients With Myelofibrosis

le Mesa, Ruben A., Kiladjian, Jean-Jacques, Catalano, John V., Devos, Timothy, Egyed, Miklos, Hellmann, Andrzei, McLornan, Donal, Shimoda, Kazuya, Winton, Elliott F., Deng, Wei, Dubowy, Ronald L., Maltzman, Julia D., Cervantes, Francisco, Gotlib, Jason
Foilsithe in J Clin Oncol (2017)

Early intervention during imatinib therapy in patients with newly diagnosed chronic-phase chronic myeloid leukemia: a study of the Spanish PETHEMA group

le Cervantes, Francisco, López-Garrido, Pilar, Montero, María-Isabel, Jonte, Fermín, Martínez, Jesús, Hernández-Boluda, Juan-Carlos, Calbacho, María, Sureda, Anna, Pérez-Rus, Gloria, Nieto, José B., Pérez-López, Cristina, Román-Gómez, José, González, Marcos, Pereira, Arturo, Colomer, Dolors
Foilsithe 2010

Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imati...

le Hughes, Timothy P., Hochhaus, Andreas, Kantarjian, Hagop M., Cervantes, Francisco, Guilhot, François, Niederwieser, Dietger, le Coutre, Philipp D., Rosti, Gianantonio, Ossenkoppele, Gert, Lobo, Clarisse, Shibayama, Hirohiko, Fan, Xiaolin, Menssen, Hans D., Kemp, Charisse, Larson, Richard A., Saglio, Giuseppe
Foilsithe 2014

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

le Hochhaus, Andreas, Larson, Richard A., Guilhot, François, Radich, Jerald P., Branford, Susan, Hughes, Timothy P., Baccarani, Michele, Deininger, Michael W., Cervantes, Francisco, Fujihara, Satoko, Ortmann, Christine-Elke, Menssen, Hans D., Kantarjian, Hagop, O’Brien, Stephen G., Druker, Brian J.
Foilsithe in N Engl J Med (2017)